Occidental Announces 4th Quarter and Full-Year 2019 Results
Get Alerts OXY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.8%
EPS Growth %: +366.7%
Join SI Premium – FREE
HOUSTON, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Occidental Petroleum Corporation (NYSE: OXY) today announced its fourth quarter and full year 2019 results. The announcement, financial schedules and accompanying slides can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the Securities and Exchange Commission's website at sec.gov.
The company will hold a conference call on Friday, February 28, 2020, at 11 a.m. Eastern/10 a.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. A recording of the webcast will be posted on the Investor Relations section of the website within several hours after the call is completed.
About Occidental
Occidental is an international oil and gas exploration and production company with operations in the United States, Middle East and Latin America. We are the leading producer and largest acreage holder in the Permian Basin. Occidental is advancing a lower-carbon future with our subsidiary Oxy Low Carbon Ventures, which promotes innovative technologies that drive cost efficiencies and economically grow our business while reducing emissions. Occidental’s marketing and midstream segment provides flow assurance for our oil and gas segment, while maximizing the value of our products. OxyChem, our chemical subsidiary, is among the top three U.S. producers for the principal products it manufactures and markets. Occidental posts or provides links to important information on our website at oxy.com.
Contacts:
Media:
Melissa E. Schoeb
713-366-5615
[email protected]
or
Investors:
Jeff Alvarez
713-215-7864
[email protected]
On the web: oxy.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Enterprises raises dividend 5%, adds board member
- Revolution Medicines starts Phase 3 trial of zoldonrasib for pancreatic cancer
- Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share